CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

RWE & Trials Live Masterclass Session 2: ‘The Tyranny of Propensity Scores’

Masterclass 2 Propensity Scores

RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’

Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series.

This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and Nawab Qizilbash, epidemiologist and clinician.

Session 2: ‘The Tyranny of Propensity Scores: The good and the bad’, will take place on Wednesday, 21 April 2021 at 5-6 pm CEST

MORE INFORMATION|REGISTER HERE

 

SUMMARY:

There is a growing use of PS methods as an alternative to conventional covariate adjustment in observational studies.

Nowadays, almost every non-randomized comparative study is expected to consider analysis using propensity scores. However, are they always the best solution to address selection bias? Furthermore, in what circumstances are certain propensity scores techniques better than others? 

MAIN TOPICS:

Introduction to PS with explanations in a non-technical way.
Description of various techniques based on Propensity Scores.
Performance of the various techniques illustrated with case studies and compared with covariate adjustment.
Discussion on limitations of these techniques.
Guidance for which methods to use and avoid in various scenarios.
Examples of propensity scores methods used in COVID-19 treatment studies illustrated from a real-time systematic review.

RESERVE YOUR SEAT!

This series is addressed to Epidemiology, HEOR, Safety, Statistics, Medical Affairs, Market Access, Marketing, Project Management and Outsourcing professionals in biopharmaceutical and device companies interested in learning about the role of Real-World Data studies and their pros and cons compared with trials.

*Due to the proprietary nature of the content, all registrations are at the discretion of OXON EPIDEMIOLOGY.